Literature DB >> 1328489

Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.

B C Das1, J K Sharma, V Gopalakrishna, U K Luthra.   

Abstract

Integration of human papillomavirus (HPV) DNA into the host cell genome is believed to be essential for malignant progression. However unambiguous detection of the physical state of HPV is a difficult and time-consuming procedure. To resolve this issue a simple, rapid and highly sensitive technique of polymerase chain reaction (PCR) has been utilized for detecting the physical state of HPV-16 DNA. Investigations were carried out in 122 cervical specimens comprising the whole spectrum of cervical lesions starting from cervical dysplasia to invasive carcinoma including HPV-16-positive normal controls. A pair of oligonucleotide primers specific to the E2 open reading frame, which is often deleted or disrupted following HPV integration, was used for the study. Distinction between episomal and integrated forms of viral DNA was accomplished by detecting amplification of the E2-specific fragment (1139 bp) in the PCR product. The PCR results were compared with those obtained by the conventional methods of Southern blotting, two-dimensional gel electrophoresis and chromosomal in situ hybridization; a high degree of agreement was observed between the methods. The findings indicate that although integrated forms of HPV-16 DNA were detected in more than 70% of cervical cancer specimens, integration was less frequent (23%) in severe dysplasia and carcinoma in situ. Only 2.5% of cases showed both episomal and integrated forms of HPV-16 DNA. The difference between episomal and integrated forms was statistically significant (P less than 0.01). The absence of integration in about 30% of cancer cases suggests that integration of HPV may not be necessary for malignant progression and alternative mechanism(s) of malignant transformation may occur without HPV integration. The PCR test thus provides an effective complement to Southern blotting and two-dimensional gel electrophoresis for accurate detection of the integration of HPV DNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328489     DOI: 10.1099/0022-1317-73-9-2327

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

1.  Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.

Authors:  R C Sobti; Neha Singh; Showket Hussain; Vanita Suri; Raje Nijhawan; A C Bharti; Mausumi Bharadwaj; B C Das
Journal:  Cell Oncol (Dordr)       Date:  2011-09-21       Impact factor: 6.730

2.  Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

Authors:  K J Watts; C H Thompson; Y E Cossart; B R Rose
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 3.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

4.  The integration of HPV-18 DNA in cervical carcinoma.

Authors:  S A Corden; L J Sant-Cassia; A J Easton; A G Morris
Journal:  Mol Pathol       Date:  1999-10

5.  Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Authors:  Shoji Nagao; Mitsuo Yoshinouchi; Yasunari Miyagi; Atsushi Hongo; Junichi Kodama; Sachio Itoh; Takafumi Kudo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction.

Authors:  V Gopalkrishna; A N Srivastava; S Hedau; J K Sharma; B C Das
Journal:  Genitourin Med       Date:  1995-08

7.  Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.

Authors:  Irfana Salam; Showket Hussain; Mohammad Muzaffar Mir; Nazir Ahmad Dar; Safiya Abdullah; Mushtaq Ahmad Siddiqi; Riyaz Ahmad Lone; Showkat Ahmad Zargar; Shashi Sharma; Suresh Hedau; Seemi Farhat Basir; Alok Chandra Bharti; Bhudev C Das
Journal:  Mol Cell Biochem       Date:  2009-06-10       Impact factor: 3.396

8.  Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection.

Authors:  Showket Hussain; Alok C Bharti; Irfana Salam; Mohammad Akbar Bhat; Mohammad Muzaffar Mir; Suresh Hedau; Mushtaq A Siddiqi; Seemi Farhat Basir; Bhudev C Das
Journal:  BMC Cancer       Date:  2009-09-16       Impact factor: 4.430

Review 9.  HPV & head and neck cancer: a descriptive update.

Authors:  Peter K C Goon; Margaret A Stanley; Jörg Ebmeyer; Lars Steinsträsser; Tahwinder Upile; Waseem Jerjes; Manuel Bernal-Sprekelsen; Martin Görner; Holger H Sudhoff
Journal:  Head Neck Oncol       Date:  2009-10-14

10.  Merkel cell polyomavirus and Merkel cell carcinoma, France.

Authors:  Vincent Foulongne; Nicolas Kluger; Olivier Dereure; Natalie Brieu; Bernard Guillot; Michel Segondy
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.